Molecular Methods in Immunohematology; Public Workshop, 48551 [E6-13695]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 161 / Monday, August 21, 2006 / Notices
of current and recent TANF recipients.
The survey will gather information from
employers on their attitudes, practices,
and policies toward TANF recipient and
other low-skill hires, including
information on worker advancement,
the use of work force intermediaries in
hiring, and the role that child care plays
in worker retention. The survey will
allow for comparisons of employers in
urban-core areas, suburbs, and exurbs/
rural areas. It will also measure
employment outcomes for TANF
recipients and other low-skilled
workers, allowing us to draw
connections between employer practices
and employee outcomes. In short, this
national survey of employers in the lowwage labor market can provide key
information on what employer practices
48551
and policies are and how they are
associated with workplace success for
welfare recipients and other less-skilled
workers.
Respondents: A nationally
representative sample of business
establishments having 4 or more
workers.
ANNUAL BURDEN ESTIMATES
Instrument
Number of respondents
Number of responses per
respondent
Average burden hours per
response
Total burden
hours
TANF Labor Market Survey .............................................................................
1,300
1
0.33
429
Estimated Total Annual Burden
Hours: 429.
Additional Information: copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, 725 17th Street, NW.,
Washington, DC 20503, Attn: Desk
Officer for ACF, E-mail address:
Katherine_T._Astrich@omb.eop.gov.
Dated: August 15, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–7036 Filed 8–18–06; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
hsrobinson on PROD1PC72 with NOTICES
[Docket No. 2006N–0320]
Molecular Methods in
Immunohematology; Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
VerDate Aug<31>2005
17:53 Aug 18, 2006
Jkt 208001
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled ‘‘Molecular Methods in
Immunohematology.’’ The purpose of
the public workshop is to gather and
review current information on scientific
developments that might enhance
immunohematologic testing of blood
donor or patient blood samples as part
of pre-transfusion compatibility testing,
or in determination and management of
feto-maternal blood group
incompatibilities.
Date and Time: The public workshop
will be held on September 25, 2006,
from 8:30 a.m. to 5 p.m., and September
26, 2006, from 8:30 a.m. to 2 p.m.
Location: The public workshop will
be held at the Lister Hill Center
Auditorium, bldg. 38A, National
Institutes of Health, 8800 Rockville
Pike, Bethesda, MD 20894.
Contact Person: Rhonda Dawson,
Center for Biologics Evaluation and
Research (HFM–302), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852–1448,
301–827–6129, FAX: 301–827–2843, email: rhonda.dawson@fda.hhs.gov.
Registration: Mail or fax your
registration information (including
name, title, firm name, address,
telephone and fax numbers) to the
contact person by September 15, 2006.
There is no registration fee for the
public workshop. Early registration is
recommended because seating is
limited. Registration on the day of the
public workshop will be provided on a
space available basis beginning at 8:00
a.m.
If you need special accommodations
due to a disability, please contact
Rhonda Dawson (see Contact Person) at
least 7 days in advance of the workshop.
SUPPLEMENTARY INFORMATION: The
public workshop will feature
presentations by national and
international experts from government,
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
academic institutions, and industry. The
main goal of the workshop is to
determine potential applications of
molecular methods to improve safety in
transfusion medicine by overcoming
current limitations in the field of
immunohematology, namely, the lack of
reagent grade antibodies, both
polyclonal and monoclonal; variability
of reactivity of monoclonal antibodies as
compared to polyclonal antibodies; and
inherent limitations in the
hemagglutination test. Topics to be
discussed include the following: (1) Use
of molecular methods in platelet and
leukocyte typing, (2) use of phage
display technology in place of routine
hemagglutination tests, (3) potential
advantages of using molecular methods
in donor screening and patient typing,
(4) use of molecular methods to resolve
unusual serologic findings, (5) potential
use of molecular methods in the
manufacture of immunohematology
reagents, and (6) current limitations in
the use of molecular methods.
Transcripts: Transcripts of the public
workshop may be requested in writing
from the Freedom of Information Office
(HFI–35), Food and Drug
Administration, 5600 Fishers Lane, rm.
6–30, Rockville, MD 20857,
approximately 15 working days after the
public workshop at a cost of 10 cents
per page. A transcript of the public
workshop will be available on the
Internet at https://www.fda.gov/cber/
minutes/workshop-min.htm.
Dated: August 14, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–13695 Filed 8–18–06; 8:45 am]
BILLING CODE 4160–01–S
E:\FR\FM\21AUN1.SGM
21AUN1
]]>Agencies
[Federal Register Volume 71, Number 161 (Monday, August 21, 2006)]
[Notices]
[Page 48551]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13695]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0320]
Molecular Methods in Immunohematology; Public Workshop
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
workshop entitled ``Molecular Methods in Immunohematology.'' The
purpose of the public workshop is to gather and review current
information on scientific developments that might enhance
immunohematologic testing of blood donor or patient blood samples as
part of pre-transfusion compatibility testing, or in determination and
management of feto-maternal blood group incompatibilities.
Date and Time: The public workshop will be held on September 25,
2006, from 8:30 a.m. to 5 p.m., and September 26, 2006, from 8:30 a.m.
to 2 p.m.
Location: The public workshop will be held at the Lister Hill
Center Auditorium, bldg. 38A, National Institutes of Health, 8800
Rockville Pike, Bethesda, MD 20894.
Contact Person: Rhonda Dawson, Center for Biologics Evaluation and
Research (HFM-302), Food and Drug Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852-1448, 301-827-6129, FAX: 301-827-2843,
e-mail: rhonda.dawson@fda.hhs.gov.
Registration: Mail or fax your registration information (including
name, title, firm name, address, telephone and fax numbers) to the
contact person by September 15, 2006. There is no registration fee for
the public workshop. Early registration is recommended because seating
is limited. Registration on the day of the public workshop will be
provided on a space available basis beginning at 8:00 a.m.
If you need special accommodations due to a disability, please
contact Rhonda Dawson (see Contact Person) at least 7 days in advance
of the workshop.
SUPPLEMENTARY INFORMATION: The public workshop will feature
presentations by national and international experts from government,
academic institutions, and industry. The main goal of the workshop is
to determine potential applications of molecular methods to improve
safety in transfusion medicine by overcoming current limitations in the
field of immunohematology, namely, the lack of reagent grade
antibodies, both polyclonal and monoclonal; variability of reactivity
of monoclonal antibodies as compared to polyclonal antibodies; and
inherent limitations in the hemagglutination test. Topics to be
discussed include the following: (1) Use of molecular methods in
platelet and leukocyte typing, (2) use of phage display technology in
place of routine hemagglutination tests, (3) potential advantages of
using molecular methods in donor screening and patient typing, (4) use
of molecular methods to resolve unusual serologic findings, (5)
potential use of molecular methods in the manufacture of
immunohematology reagents, and (6) current limitations in the use of
molecular methods.
Transcripts: Transcripts of the public workshop may be requested in
writing from the Freedom of Information Office (HFI-35), Food and Drug
Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857,
approximately 15 working days after the public workshop at a cost of 10
cents per page. A transcript of the public workshop will be available
on the Internet at https://www.fda.gov/cber/minutes/workshop-min.htm.
Dated: August 14, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-13695 Filed 8-18-06; 8:45 am]
BILLING CODE 4160-01-S
